VCI Global’s CyberSecure Cloud Goes Live in Malaysia, Setting New Standard for Encrypted Data Protection 30-08-2025, 02:30

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Duck Creek Technologies Launches Policy with Active Delivery 5-08-2024, 19:30